Do intraocular Angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy

Acta Ophthalmologica Scandinavica

Volumn 76, Issue 5, 1998, Pages 533-536

  Lip, Peck Lin ^a   Jones, Alan F ^a   Price, Nicholas ^b   Headon, Maurice ^b   Gareth Beevers, D ^a   Lip, Gregory Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

^b Wolverhampton Midland Counties E   (United Kingdom)

Author keywords

Angiotensin; Diabetic retinopathy; Vasoproliferative

Indexed keywords

ANGIOTENSIN; FIBRINOGEN; LIPOPROTEIN; LIPOPROTEIN A; PADGEM PROTEIN;

ADULT; AGED; ANGIOTENSIN BLOOD LEVEL; AQUEOUS HUMOR; ARTICLE; BLOOD RHEOLOGY; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL;

EID: 0031787764     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.1998.760504.x     Document Type: Article

References (12)

1. Blann AD, Lip GYH (1997): Is soluble P-selectin a new marker of platelet activation? Atherosclerosis 128: 135-138.
2. Blann AD, Taberner DA (1995): A reliable marker of endothelial cell dysfunction: Does it exist? Br J Haem 90: 244-248.
3. Danser AHJ, van den Dorpel MA, Deinum J et al (1989): Renin, prorenin and immunoreactive renin in vitrous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 68: 160-167.
4. Davis MD (1989): Proliferative retinopathy. In: Ryan SJ (ed). Retina. St Louis. CV Mosby Co. Volume 2: 367-402.
5. Drury PL, Bodansky HJ, Oddie CJ, Cudworth AG, Edwards CRW (1982): Increased plasma renin activity in type I diabetes with microvascular disease. Clin Endcrinol 16: 453-461.
6. Lip GYH, Blann AD (1997): von Willebrand factor: a marker of endothelial dysfunction in cardiovascular disorders. Cardiovasc Res 34: 255-265.
7. Lip GYH, Jones AF (1995): Lipoprotein (a) and vascular disease: Thrombogenesis and Atherogenesis. QJM 88: 529-539.
8. Luetscher JA, Kraemer FB, Wilson DM (1989): Prorenin and vascular complications of diabetes. Am J Hypertens 2: 382-386.
9. Nussberger J, Brunner HR (1993): Measurement of angiotensins in plasma. In: Robertson JIS. Nicholls MC (ed) The renin-angiotensin system. London. Gower Medical Publishing. 15.1-15.13.
10. Osusky R, Nussberger J, Amstutz C, Flammer J, Brunner HR (1994): Individual measurements of angiotensin II concentrations in aqueous humor of the eye. Eur J Ophthal 4: 228-233.
11. Sechi LA, Kronenberg F, Carli SD et al (1997): Association of serum lipoprotein (a) levels and apolipoprotein (a) size polymorphism with target organ damage in arterial hypertension. JAMA 277: 1689-1695.
12. Weidmann P, Ferrari P, Shaw SG (1993): Renin in diabetes mellitus. In: Robertson JIS, Nicholls MC (ed) The renin-angiotensin system. London. Gower Medical Publishing. 75.1-75.26.